Lee Mayer Ocuin
Research Subjects
Lee Mayer Ocuin has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
Jeffrey M. Hardacre
Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, USA
43 shared publicationsJohn B. Ammori
Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, USA
38 shared publicationsJordan M. Winter
Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, USA
34 shared publicationsLuke D. Rothermel
Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, USA
23 shared publicationsJonathan J. Hue
Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, USA
20 shared publicationsDavid Bajor
Department of Medicine, Division of Hematology/Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, USA
15 shared publications
Latest Publications
- 6 May 2026
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 30 (7) , 102449
Invited commentary on: “Post-surgical ctDNA as a prognostic biomarker for relapse of resected pancreatic ductal adenocarcinoma”
- 6 May 2026
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 30 (7) , 102449
Invited commentary on: “Post-surgical ctDNA as a prognostic biomarker for relapse of resected pancreatic ductal adenocarcinoma”
- Open Access
- 22 March 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (6) , 4899-4901
Care Fragmentation following Upper Gastrointestinal and Hepatopancreatobiliary Cancer Surgery: Consequences for Patients and Healthcare Systems
- 22 March 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (6) , 4899-4901
Open AccessCare Fragmentation following Upper Gastrointestinal and Hepatopancreatobiliary Cancer Surgery: Consequences for Patients and Healthcare Systems
- Open Access
- 1 August 2025
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 16 (4) , 1768-1772
The surgical perspective on CAIRO5 and beyond: all patients with colorectal liver metastases should be evaluated by a liver surgeon, but what defines resectability?
The surgical perspective on CAIRO5 and beyond: all patients with colorectal liver metastases should be evaluated by a liver surgeon, but what defines resectability?
- 1 August 2025
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 16 (4) , 1768-1772
Open AccessThe surgical perspective on CAIRO5 and beyond: all patients with colorectal liver metastases should be evaluated by a liver surgeon, but what defines resectability?
The surgical perspective on CAIRO5 and beyond: all patients with colorectal liver metastases should be evaluated by a liver surgeon, but what defines resectability?
- Open Access
- 13 August 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (10) , 6586-6587
ASO Author Reflections: Comparison of Hospital Volume and Risk-Standardized Mortality Rate as a Proxy for Hospital Quality in Complex Oncologic Hepatopancreatobiliary Surgery
- 13 August 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (10) , 6586-6587
Open AccessASO Author Reflections: Comparison of Hospital Volume and Risk-Standardized Mortality Rate as a Proxy for Hospital Quality in Complex Oncologic Hepatopancreatobiliary Surgery
- 10 August 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (10) , 6598-6599
ASO Visual Abstract: Comparison of Hospital Volume and Risk-Standardized Mortality Rate as a Proxy for Hospital Quality in Complex Oncologic Hepatopancreatobiliary Surgery
- 10 August 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (10) , 6598-6599
ASO Visual Abstract: Comparison of Hospital Volume and Risk-Standardized Mortality Rate as a Proxy for Hospital Quality in Complex Oncologic Hepatopancreatobiliary Surgery
- Open Access
- 5 August 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (12) , 7676-7678
Management of Localized Intrahepatic Cholangiocarcinoma: What Exactly is the ‘Evidence’?
- 5 August 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (12) , 7676-7678
Open AccessManagement of Localized Intrahepatic Cholangiocarcinoma: What Exactly is the ‘Evidence’?